Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
The OTCQX's Top 10 Experience A Shuffle In February
March 15, 2022
Tickers
ADDYY
ETHE
GBOOY
GBTC
Tags
ONEQ
Partner Content
ZURVY
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
ESALY
ANAB
News
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
BAYRY
EXEL
BAYZF
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
Benzinga
Market News
RHHBY
From
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Tickers
ACIU
ADAP
ALDX
ALEC
Tags
TCON
PYPD
MRK
From
Benzinga
OTC Markets 2021 Annual Data Review Highlights A Record 60% $ Volume Increase
March 07, 2022
Tickers
BVNNF
GBTC
OTCM
RHHBY
Tags
Small Cap
GBTC
otc markets
From
Benzinga
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
March 04, 2022
Tickers
AZN
HRTX
JNJ
LEGN
Tags
Recent Press Releases
RHHBY
LEGN
From
Motley Fool
Viatris Just Snagged a Major FDA Approval
March 03, 2022
Tickers
ABBV
NVS
REGN
RHHBY
Tags
SNY
NVS
Market News
From
Motley Fool
2 Biotech Stocks That Could Make You Richer
March 02, 2022
Tickers
BMY
EXEL
ICPT
RHHBY
Tags
BMY
Recent Press Releases
RHHBY
From
Motley Fool
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
Tickers
AZN
AZNCF
RHHBY
TAK
Tags
Health Care
Biotech
AZN
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
Benzinga
Market News
ANY
From
Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
Tickers
ARVN
BIIB
CCCC
GOOG
Tags
VRTX
PFE
CCCC
From
Motley Fool
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
Tickers
BNPQY
CYDY
EEENF
ETHE
Tags
GBTC
FMCC
TOMDF
From
Benzinga
Why Are Seagen Shares Sinking Today?
February 10, 2022
Tickers
GSK
MRK
RHHBY
SGEN
Tags
General
RHHBY
Movers
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
CLSD
LOGC
General
From
Benzinga
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
February 05, 2022
Tickers
ARKG
BNTX
MRK
PFE
Tags
REGN
BNTX
Long Ideas
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Tickers
ABMD
ARWR
BIIB
BMY
Tags
FDA
SYRS
MRSN
From
Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
February 03, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Biotech
Health Care
Market News
From
Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
February 02, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Guidance
RHHBF
RHHVF
From
Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
Follicular Lymphoma
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
RHHBY
EW
News
From
Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
January 31, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Benzinga
FDA
Age/Related Macular Degeneration
From
Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
January 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
Briefs
Biotech
From
Benzinga
These OTC Securities Had the Most Trading Activity in December
January 25, 2022
Tickers
ADDYY
AKZOY
BNPQY
CYDVF
Tags
Market News
Penny Stocks
DTEGY
From
Benzinga
3 Clinical Trials to Watch in the First Half of 2022
January 22, 2022
Tickers
ABBV
ARNA
BIIB
JPM
Tags
VRTX
PFE
Market News
From
Motley Fool
2 Risky Growth Stocks That Could Make You Filthy Rich
January 16, 2022
Tickers
AZN
BGNE
JPM
LPTX
Tags
AZN
PIRS
RHHBY
From
Motley Fool
Where Will Biogen Be in 5 Years?
January 15, 2022
Tickers
BIIB
NVS
RHHBY
SAGE
Tags
NVS
Market News
RHHBY
From
Motley Fool
Medicare pulls back on coverage of an Alzheimer’s drug
January 12, 2022
Tickers
BIIB
LLY
RHHBY
Tags
RHHBY
BIIB
LLY
From
MarketWatch
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
RHHBF
RHHVF
ESALF
From
Benzinga
Why Shares of ImmunoGen Jumped 20.3% in December
January 03, 2022
Tickers
IMGN
RHHBY
Tags
Recent Press Releases
RHHBY
Market News
From
Motley Fool
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.